Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis C

Free Subscription Articles published in Eur J Gastroenterol Hepatol Retrieve available abstracts of 47 articles: HTML format Text format

Single Articles

February 2010
1. CHEUNG KJ , Libbrecht L, Tilleman K, Deforce D, et al
   Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis.
   Eur J Gastroenterol Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. DALGARD O , Bjoro K, Ring-Larsen H, Verbaan H, et al
   In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials.
   Eur J Gastroenterol Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
3. EL-SHABRAWI MH , Mohsen NA, Sherif MM, El-Karaksy HM, et al
   Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.
   Eur J Gastroenterol Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. KAJIHARA M , Montagnese S, Khanna P, Amodio P, et al
   Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two cases.
   Eur J Gastroenterol Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. ALAVIAN SM , Tabatabaei SV
   Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
   Eur J Gastroenterol Hepatol. 2010;22:123-4.
   PubMed     Text format     Related articles   
   
   
   
6. KATO H , Nakamura M, Nakamura A, Ueda R, et al
   A case of compensated liver cirrhosis with hepatitis C virus of genotype 1b and high viral load in whom sustained virological response was achieved by 2-year administration of very low-dose recombinant interferon alpha-2b.
   Eur J Gastroenterol Hepatol. 2010;22:121-2.
   PubMed     Text format     Related articles   
   
   
   December 2009
7. GIORDANO C , Cooper C
   The influence of race and language on chronic hepatitis C virus infection management.
   Eur J Gastroenterol Hepatol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. MOHAN P , Rajasekaran M, Ramanathan P, Venkataraman J, et al
   Prevalence of hepatitis C virus antibodies in systemic lupus erythematosus.
   Eur J Gastroenterol Hepatol. 2009;21:1437-8.
   PubMed     Text format     Related articles   
   
   
   
9. DIMITROULOPOULOS D , Petroulaki E, Manolakopoulos S, Anagnostou O, et al
   Peginterferon/ribavirin treatment achieves a higher compliance rate than interferon/ribavirin combination in patients chronically infected with HCV on methadone maintenance.
   Eur J Gastroenterol Hepatol. 2009;21:1407-12.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
10. ZEKRI AR , Moharram RA, Mohamed WS, Bahnassy AA, et al
    Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
11. KOK KF , van Soest H, van Herwaarden AE, van Oijen MG, et al
    Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapy.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. MCDONALD SA , Hutchinson SJ, Bird SM, Mills PR, et al
    Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. NEUKAM K , Recio E, Camacho A, Macias J, et al
    Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometry.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. MORIN T , Pariente A, Lahmek P, Rabaud C, et al
    Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
15. DINTSIOS CM , Haverkamp A, Wiegand J, Gerlach T, et al
    Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. BECKER VR , Badiani RG, Lemos LB, Perez RM, et al
    Factors associated with the progression of hepatic fibrosis in end-stage kidney disease patients with hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. CAZZANIGA M , Salerno F, Borroni G, Ceriani R, et al
    Prediction of asymptomatic cirrhosis in chronic hepatitis C patients: accuracy of artificial neural networks compared with logistic regression models.
    Eur J Gastroenterol Hepatol. 2009;21:681-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
18. TAJIRI H , Inui A, Kiyohara Y, Suzuki M, et al
    Peginterferon alpha-2b and ribavirin for the treatment of chronic hepatitis C in Japanese pediatric and young adult patients: a survey of the Japan Society of Pediatric Hepatology.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. CROSS TJ , Rizzi P, Berry PA, Bruce M, et al
    King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
20. ANCEL D , Amiot X, Chaslin-Ferbus D, Hagege I, et al
    Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. MURTHY GD , Vu K, Venugopal S
    Prevalence and treatment of hyperlipidemia in patients with chronic hepatitis C infection.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. GARCIA-FULGUEIRAS A , Garcia-Pina R, Morant C, Garcia-Ortuzar V, et al
    Hepatitis C and hepatitis B-related mortality in Spain.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. TELAKIS E , Nikolaou A
    Localized scleroderma (morphea) in a patient with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2009;21:486.
    PubMed     Text format     Related articles   
    
    
    
24. LO YC , Chang SY, Sheng WH, Hung CC, et al
    Association of pancreatic autoantibodies and human leukocyte antigen haplotypes with resolution of diabetes mellitus after therapy for hepatitis C virus infection in patients with HIV infection: case report and review of literature.
    Eur J Gastroenterol Hepatol. 2009;21:478-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. NARCISO-SCHIAVON JL , Freire FC, Suarez MM, Ferrari MV, et al
    Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon?
    Eur J Gastroenterol Hepatol. 2009;21:440-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
26. GIORDANO C , Druyts EF, Garber G, Cooper C, et al
    Evaluation of immigration status, race and language barriers on chronic hepatitis C virus infection management and treatment outcomes.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. DUFOUR JF , Pradat P, Ruivard M, Hot A, et al
    Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases.
    Eur J Gastroenterol Hepatol. 2009;21:245-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
28. MUSIALIK J , Petelenz M, Blonska-Fajfrowska B, Hartleb M, et al
    Pernicious anemia during peginterferon-alphaalpha2b plus ribavirin therapy for chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
29. SEWELL JL , Stick KM, Monto A
    Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy.
    Eur J Gastroenterol Hepatol. 2009;21:225-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
30. GRIER S , Patel N, Kuo YT, Cosgrove DO, et al
    Perihepatic lymph nodes as markers of disease response in patients with hepatitis C-related liver disease: a prospective clinical evaluation.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. BOURSIER J , Bacq Y, Halfon P, Leroy V, et al
    Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2009;21:28-38.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
32. BOZKURT H , Kurtoglu MG, Bayram Y, Kesli R, et al
    Distribution of hepatitis C prevalence in individuals according to their age level in Eastern Turkey.
    Eur J Gastroenterol Hepatol. 2008;20:1249.
    PubMed     Text format     Related articles   
    
    
    
33. RENOU C , Cadranel JF, Pariente A, Penaranda G, et al
    Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers.
    Eur J Gastroenterol Hepatol. 2008;20:1235-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
34. JOHNSON K , Sargent LA, Galizio C, Ubogu EE, et al
    Interferon-alpha-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient.
    Eur J Gastroenterol Hepatol. 2008;20:1110-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. NARCISO-SCHIAVON JL , Schiavon LL, Carvalho-Filho RJ, Cardoso JR, et al
    Anti-HCV reactive blood donors: clinical and epidemiological factors associated with false-reactive results.
    Eur J Gastroenterol Hepatol. 2008;20:1071-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
36. CADRANEL JF , Di Martino V, Lambrey G, Mourlhon C, et al
    Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2008;20:829-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
37. RAZIORROUH B , Jung MC, Schirren CA, Loehe F, et al
    Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Eur J Gastroenterol Hepatol. 2008;20:778-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
38. GROSSMANN SDE M , Teixeira R, de Aguiar MC, do Carmo MA, et al
    Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Eur J Gastroenterol Hepatol. 2008;20:702-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. ANGELICO M , Koehler-Horst B, Piccolo P, Angelico F, et al
    Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonrespond
    Eur J Gastroenterol Hepatol. 2008;20:680-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. DI COSTANZO GG , De Luca M, Tritto G, Lampasi F, et al
    Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.
    Eur J Gastroenterol Hepatol. 2008;20:674-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
41. ABE S , Narita R, Matsuhashi T, Oto T, et al
    Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2008;20:373-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. DEFOSSEZ G , Verneau A, Ingrand I, Silvain C, et al
    Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
    Eur J Gastroenterol Hepatol. 2008;20:367-372.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
43. LUBRANO J , Rouquette A, Huet E, Francois A, et al
    Ciliated hepatic foregut cyst discovered after kidney transplantation in a hepatitis C virus-infected patient: a report of one case and review of the literature.
    Eur J Gastroenterol Hepatol. 2008;20:359-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
44. SJOBERG K , Widell A, Verbaan H
    Prevalence of hepatitis C in Swedish diabetics is low and comparable to that in health care workers.
    Eur J Gastroenterol Hepatol. 2008;20:135-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
45. GROSSI S , Sumberaz A, Gosmar M, Mattioli F, et al
    DNA damage in peripheral blood lymphocytes of patients with cirrhosis related to alcohol abuse or to hepatitis B and C viruses.
    Eur J Gastroenterol Hepatol. 2008;20:22-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2007
46. SCHOTT E , Witt H, Pascu M, van Boemmel F, et al
    Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.
    Eur J Gastroenterol Hepatol. 2007;19:947-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. KIM DO Y , Ahn SH, Lee HW, Kim SU, et al
    Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea.
    Eur J Gastroenterol Hepatol. 2007;19:923-6.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: